Endometrial cancer is the most common gynecologic cancer, with more than 69,000 cases diagnosed in the U.S. in 2025 and ...
Every year, about 85,000 Americans are diagnosed with bladder cancer. While treatment is often successful, bladder cancer has one of the highest rates of recurrence of any cancer: Following treatment, ...
Gastric cancer remains one of the leading causes of cancer-related mortality worldwide, primarily due to late-stage diagnosis ...
Researchers are calling for the application of locally driven strategies, supported by stronger regional evidence, to improve early cancer detection and precise care.
Share on Pinterest New colorectal cancer screening guidelines include blood-based and at-home stool tests. Jacob Wackerhausen/Getty Images The American Cancer Society (ACS) has updated its colorectal ...
Arrays of resonant nanoparticles, so-called metasurfaces, have been developed and demonstrated as the first generation of meta-operators. Unlike today’s electronic systems, the demonstrated compact, ...
Professor Jinyang Liang, specializing in ultrafast imaging and biophotonics at INRS, has developed with colleagues at INRS and Université de Montréal a minimally invasive technology to detect skin ...
The test can screen for more than 50 types of cancer using a single blood sample, but doctors say it is important to understand both its benefits and limitations. Cancer remains one of the leading ...
Multi-category Personal Protective Equipment (PPE) non-compliance monitoring on construction sites remains challenging because visual cues for missing PPE often appear at multiple scales, particularly ...
An annual blood test designed to detect multiple cancers before symptoms appear is "feasible at scale" on the NHS, experts have said. The Galleri test works by identifying DNA shed by cancer cells in ...
AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...
Integrated data platform: Backbone of cancer research office. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results